I am the Chief of Stanford BMT and Cell Therapy Program that provides 750 cancer cell therapies annually. Our BMT-CT research fosters the development of both laboratory immunologists, and clinical translational researchers. Our allogeneic hematopoietic cell transplantation (alloHCT) research is optimizing graft content of HSC, conventional T lymphocyte, and regulatory T cell content in order to cures blood cancers via beneficial graft-v-tumor (GVT) immunity while reducing GVHD risk. Our CAR-T research provides the most direct targeting of cancer and is dramatically improving leukemia and Lymphoma with no GVHD risk. Our goal is to combine graft engineered allogeneic HCT with CAR-T benefit.
ServicesDavid Miklos provides surgery in Palo Alto, CA. The most common types of surgeons are: General, Cardiovascular, Otolaryngology, Neurological, Reconstructive, Neonatal and Orthopedic.
Please call David Miklos, MD, PhD at (650) 498-6000 to schedule an appointment in Palo Alto, CA or to get more information.Additional ServicesHematologist